Nasal COVID-19 vaccine approved for use as booster in India

Science Instruments in laboratory room. Science Research Concept.

A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines. The approval follows the Indian government’s emergency use authorization in September of the vaccine as a primary series of two doses, and makes the intranasal vaccine the world’s first to receive approval as both a primary vaccine for COVID-19 and a booster.

The second-gen Apple Pencil is back down to its record-low Cyber Week price

Previous article

Possible therapeutic approach to fight incurable blood cancer

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations